Plant Health Care said on Thursday it expects annual results to show an operating loss 'slightly better than expectations'.
In a trading update, the provider of novel patent protected biological products to the global agriculture markets projected an operating loss of $6.5m for the year to the end of December.
Cash and short-term liquid investments were also exceeded expectations at $7.7m, the company said.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Revenues are pegged at $7.8m, similar to last year. The company said revenues would have been higher if its partnership agreement for foliar Harpin was completed by the end of year. They expect to tie up loose ends in the first quarter of 2013.
Shares jumped 2.53% to 81.00p following the announcement.
"The board continues to be excited about the ability of the company to bring existing and new patented products to the market over the coming years," the company said in a statement.
"However, the precise timing of additional partnership agreements remains unpredictable in the automative industry."
RD
-
Shein shifts IPO focus to Hong KongThe development piles fresh pressure on London’s beleaguered stock market, which many had hoped would be boosted by Shein’s IPO
-
Scientists turn lead into gold – could it wreck the yellow metal's price?Medieval alchemists have been vindicated after scientists turned lead into gold, but the results aren’t going to crash the gold price any time soon
